According to the research report titled ‘GLOBAL Botulinum Toxin Market 2021-2028’, available with Market Study Report, global botulinum toxin market is projected to expand at an annual rate of 5.55% between 2021-2028.
 

Surging geriatric population coupled with flourishing medical tourism are key factors spurring global botulinum toxin market growth. Moreover, extensive application in various therapeutics and rising cognizance regarding personal aesthetics will aid industry expansion in the forthcoming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3855547/
 

On the other hand, high concerns over limited interchangeability and lack of proper reimbursement policies for supporting cosmetic procedures are poised to hinder global botulinum toxin market proliferation.
 

Based on type, the industry is bifurcated into type A and type B. Speaking of application scope, the market space is divided into cosmetic applications and non-cosmetic applications. Moving on to end user spectrum, the business sphere is classified into hospitals, and clinics & others.
 

The report analyses this business space extensively and provides detailed information pertaining to growth rate estimates and market share held by each company over the analysis timeframe.
 

Regionally speaking, Asia Pacific held majority of the worldwide botulinum toxin industry share in the recent past and is projected to grow rapidly between 2021-2028.
 

Rising disposable income along with growing geriatric population have boosted demand for anti-aging products. Furthermore, rising social awareness pertaining to commercial availability of anti-aging products will aid market expansion in the Asia Pacific in the upcoming years.
 

Key players profiled in the report are US WorldMeds LLC, AbbVie Inc., Revance Therapeutics Inc., Evolus Inc., Hugel Inc., Galderma Pharma S.A., Medy-Tox Inc., Ipsen Pharma Biotech SAS, and Merz Pharma GmbH & Co. KGaA.
 

These companies have made strategic moves like partnerships, alliances, investments in research & development, product launches, and mergers & acquisitions to increase profits and strengthen their foothold in this business sphere.